Norris Medicines has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on May 22, 2016, to consider and approve, Audited Financial Results year ended on March 31, 2016. Further in accordance with Company’s Code of Conduct for Prevention of Insider Trading, the Trading window for dealing in the securities of the Company will be closed for all directors, and designated personnel of the Company from May 18, 2016 and end 48 hours after the results are made public on May 22, 2016.
The above information is a part of company’s filings submitted to BSE.
